AGP Limited has approved an arrangement with an associated company to manufacture and market Viagra in Pakistan, with the product expected to be launched in May 2026, according to a notice sent to the Pakistan Stock Exchange.

The listed pharmaceutical company said its board of directors approved the arrangement at a meeting held on April 29, 2026.

Under the proposed arrangement, AGP will act as the contract manufacturing organization for Viagra and will also receive marketing rights for the product in Pakistan. The company said the required agreements are being finalized and the launch is expected in May 2026, subject to completion of formalities.

AGP disclosed that it will provide contract manufacturing and marketing services under the deal as part of its expansion in the local pharmaceutical market.

Incorporated in Pakistan in 2014, AGP Limited is engaged in the import, export, marketing, distribution, dealership and manufacturing of a broad range of pharmaceutical products.

The company said Aitkenstuart Pakistan (Private) Limited holds 55.80 percent of its share capital, while West End 16 Pte Limited of Singapore is its ultimate parent company.

AGP distributes its products through Muller & Phipps Pakistan (Private) Limited, which provides access to more than 46,000 pharmacies across the country.